Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 nivolumab monotherapy in biliary tract cancer (ONO-4538-32)
jRCT2080223044Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Dec 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nivolumab in biliary cancer, sponsored by Ono Pharmaceutical. Started Dec 2015; status: completed.
02
Drugs
03
Conditions
biliary cancer
Beyond the preview
Go deeper on jRCT2080223044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223044.